Healthcare Medical Devices Biotechnology

Neurorehabilitation Devices Market

Global Industry Analysis and Forecast 2023-2030

Pages : 120

Base Year : 2022

Release Year : April 2024

Format : Pdf Ppt Xls

Report ID: KR137

Author : Shreya S.

Base Year

2022

Forecast Year

2023-2030

Historical Years

2018-2021

Market Value (2022)

USD 1.96 Billion

Forecasted Value (2030)

USD 5.63 Billion

CAGR (2023 - 2030)

14.32%

Fastest Growing Region (2023 - 2030)

North America

Largest Region

Asia-Pacific

By Product

Neurorobotic Systems, Brain-computer Interface, Wearable Devices, Brain Stimulators

By Application

Stroke, Brain & Spinal Cord Injury, Parkinson’s Disease, Cerebral Palsy • Multiple Sclerosis • Others

By End User

Rehabilitation Centers, Hospitals & Clinics, Home Care, Others


infographics Img
CHOOSE LICENCE TYPE
CUSTOMIZATION OFFERED
  • Check Icon Additional Company Profiles
  • Check Icon Additional Countries
  • Check Icon Cross Segment Analysis
  • Check Icon Regional Market Dynamics
  • Check Icon Country-Level Trend Analysis
  • Check Icon Competitive Landscape Customization
  • Check Icon Extended Forecast Years
  • Check Icon Historical Data Up to 5 Years
Frequently Asked Questions (FAQ's)
The global neurorehabilitation devices market is projected to reach USD 5.63 billion by 2030, growing at a CAGR of 14.32% from 2023 to 2030.
The global neurorehabilitation devices market was valued at USD 1.96 billion in 2022.
The market for neurorehabilitation devices has grown significantly in recent years due to several factors which include the prevalence of neurological diseases, increasing awareness of the effectiveness of neurorehabilitation therapy, and technological advances in medical devices.
Top manufacturers of neurorehabilitation devices market are AIMedical International Pty Ltd, BIONIK, Ectron, Ekso Bionics, eodyne, Evolution Devices, Gloreha IDROGENET s.r.l., Helius Medical Technologies, Inc., Lupin, Medtronic, MindMaze, Neurofenix, Inc., Sumitomo Pharma Co., Ltd. and others.
Asia-Pacific is the fastest growing region with the CAGR of 16.16% in the forecasted period (2023-2030) with the market value forecasted to reach at USD 1.27 billion.
By product, neurorobotic systems will hold the maximum share in the neurorehabilitation devices market with the revenue value of USD 2.56 billion in 2030.
Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership